Day: January 28, 2026

Wrap Advances WrapVision with U.S Produced, NDAA-Compliant Next-Generation IONODES PERCEPT Body-Worn Camera Platform

Written by Customer Service on January 28, 2026. Posted in Public Companies.

Meets United States Country of Origin (COO) Requirements for Regulated Public Safety Deployments MIAMI, Jan. 28, 2026 (GLOBE NEWSWIRE) — Wrap Technologies, Inc. (NASDAQ: WRAP) (“Wrap” or, the “Company”), a global leader in non-lethal response and public safety technology, today announced the launch of the latest generation WrapVision body-worn camera platform, powered by the IONODES PERCEPT BC200, a next-generation body-worn video solution engineered to deliver flexibility, interoperability, and security for mission-critical operations. WrapVision with the PERCEPT BC200 body camera is purpose-built for regulated public safety and enterprise environments, with a strong emphasis on United States Country of Origin, NDAA compliance, and long-term procurement confidence. The platform is designed to reduce supply-chain and geopolitical...

Hecate Energy Group Announces Investor Webinar on February 5, 2026

Written by Customer Service on January 28, 2026. Posted in Public Companies.

CHICAGO, Jan. 28, 2026 (GLOBE NEWSWIRE) — Hecate Energy Group LLC (“Hecate”), an independent energy infrastructure developer, and EGH Acquisition Corp. (NASDAQ: EGHA, EGHAU, EGHAR) (“EGH”), today announced that they will host an investor webinar to introduce Hecate, its operations, and near-term strategy on February 5, 2026, at 10:00 a.m. Eastern Time. During the event, management will provide an overview of Hecate’s diversified utility-scale energy development platform spanning solar, battery storage, wind, and thermal generation, and discuss the proposed transaction that would result in Hecate becoming a publicly listed company on Nasdaq. The event will be streamed live and we highly encourage prospective investors, analysts, and the financial media to register for the event here. About Hecate Energy LLC Headquartered in Chicago,...

Kornit Digital Sets Fourth Quarter and Full Year 2025 Earnings Release Date and Webcast

Written by Customer Service on January 28, 2026. Posted in Public Companies.

ROSH-HA`AYIN, Israel, Jan. 28, 2026 (GLOBE NEWSWIRE) — Kornit Digital Ltd. (NASDAQ: KRNT) (“Kornit” or the “Company”), a global pioneer in sustainable, on-demand, digital fashion and textile production technologies, announced today that it will release its financial results for the fourth quarter and full year ended December 31, 2025 on Wednesday, February 11th, prior to the market open. The Company will host an earnings conference call and webcast reviewing these results and its operations on Wednesday, February 11, 2026 at 8:30 am ET. This conference call will be broadcast live and can be accessed by all interested parties through Kornit’s website, www.kornit.com, in the “Investors” section. The dial-in information for the live call is: Live Call: 1-877-407-0792 or 1-201-689-8263Israel Toll Free: 1 809 406 247 A...

BriaCell Patients’ Images Show Regression and Resolution of Metastasized Tumors and Immune Activation

Written by Customer Service on January 28, 2026. Posted in Public Companies.

Images below confirm clinical responses seen in patients with metastatic orbital (eye), temporal (brain), liver, and spine lesions No Bria-IMT™ related discontinuations reported to date Bria-IMT regimen continues under Fast Track Designation from US FDAPHILADELPHIA and VANCOUVER, British Columbia, Jan. 28, 2026 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, releases new images highlighting resolution of metastatic breast cancer lesions in patients with orbital (eye), temporal lobe (brain), liver, and spinal involvement. Survival details on these and other select patients in its Phase 2 study, along with comparable populations, were previously reported.Table...

Vireo Growth Inc. Enters into Non-Binding Memorandum of Understanding to Acquire The Hawthorne Gardening Company from ScottsMiracle-Gro

Written by Customer Service on January 28, 2026. Posted in Mergers And Acquisitions.

Planned share-based transaction is expected to be completed during the first fiscal quarter of 2026 Vireo plans to appoint Chris Hagedorn to its Board of Directors MINNEAPOLIS, Jan. 28, 2026 (GLOBE NEWSWIRE) — Vireo Growth Inc. (“Vireo”) (CSE: VREO; OTCQX: VREOF) (“Vireo” or the “Company”) today announced that it has entered into a nonbinding Memorandum of Understanding (“MOU”) with The Scotts Miracle-Gro Company to acquire The Hawthorne Gardening Company LLC (“Hawthorne”), an independent operating subsidiary of ScottsMiracle-Gro and leading provider of nutrients, lighting and other materials used for indoor and hydroponic gardening in North America. John Mazarakis, Chief Executive Officer of Vireo, commented, “We’ve valued our working relationship with ScottsMiracle-Gro and the Hawthorne team, and they have been excellent to work...

Teva Innovative Portfolio and Consistent Execution of Pivot to Growth Strategy Deliver Third Consecutive Year of Growth; Pipeline Positioned to Unlock Significant Value Potential

Written by Customer Service on January 28, 2026. Posted in Earnings Releases And Operating Results.

Teva delivers 3 consecutive years of growth – 2025 revenues of $17.3 billion, an increase of 4% year-over-year (YoY) in U.S. dollars, or 3% in local currency (LC) terms, compared to 2024. Excluding Japan BV, revenues increased 5% YoY in LC. Key Innovative brands continued to drive growth and provide value for patients, with 2025 revenues surpassing $3 billion, +35% YoY in LC:AUSTEDO® global revenues of $2.26 billion, growing 34% YoY in LC.AJOVY® global revenues of $673 million, up 30% YoY in LC. UZEDY® revenues of $191 million, up 63% YoY in LC; underscoring Teva’s commitment to drive new advances in neuroscience:Fastest growing long-acting injectable (LAI)1 FDA expanded indication approval for Bipolar 1 Disorder.Q4 2025 marks the first quarter in which these key brands collectively delivered ~$1 billion of revenues.Generics...

Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates

Written by Customer Service on January 28, 2026. Posted in Earnings Releases And Operating Results.

Interim results from Phase 2b clinical trial of RAD 101 showed 92% of evaluable participants met the primary endpoint of MRI concordance in imaging study of patients with brain metastases Interim data from additional Cohorts of the Phase 1 clinical trial of RAD 202 and RAD 204 in advanced solid tumors are expected in mid-2026 Cash and cash equivalents of approximately $34.52 million provide runway into 2027 to advance pipeline of high value radiotherapeutic programs through key clinical and regulatory milestones SYDNEY, Jan. 28, 2026 (GLOBE NEWSWIRE) — Radiopharm Theranostics (ASX: RAD, Nasdaq: RADX, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, today announced financial results for the first six months...

DoubleDown Interactive to Report 2025 Fourth Quarter Results on February 11 and Host Conference Call and Webcast

Written by Customer Service on January 28, 2026. Posted in Earnings Releases And Operating Results.

SEOUL, South Korea, Jan. 28, 2026 (GLOBE NEWSWIRE) — DoubleDown Interactive Co., Ltd. (NASDAQ: DDI) (“DoubleDown” or the “Company”), a leading developer and publisher of digital games on mobile and web-based platforms, announced today that it will release its 2025 fourth quarter financial results after the market closes on Wednesday, February 11, 2026, and host a conference call and simultaneous webcast at 5:00 p.m. ET (2:00 p.m. PT) that day. Both the call and webcast are open to the general public. On the call, DoubleDown management will review the Company’s financial results and provide a business update, followed by a question-and-answer session. To access the call, please use the following link: DoubleDown Fourth Quarter 2025 Earnings Call. After registering, an email will be sent, including dial-in details and a unique conference...

ScottsMiracle-Gro Reports First Quarter Results and Advancement of Key Strategic Initiatives

Written by Customer Service on January 28, 2026. Posted in Earnings Releases And Operating Results.

Announces divestiture plan for Hawthorne Unveils new multi-year share repurchase program to commence in late 2026 MARYSVILLE, Ohio, Jan. 28, 2026 (GLOBE NEWSWIRE) — The Scotts Miracle-Gro Company (NYSE: SMG), the leading marketer of branded consumer lawn and garden products in North America, today reported results for the first quarter ended December 27, 2025. The Company also announced that it is in advanced discussions for the sale of its Hawthorne subsidiary to Vireo Growth, Inc., with an anticipated closing in the fiscal second quarter. In conjunction with the pending divestiture, effective in its first quarter of fiscal 2026, the Company classified its results of operations for all periods presented to reflect the Hawthorne business as a discontinued operation. The Company is reaffirming its fiscal 2026 guidance, as the classification...

Fidelity D & D Bancorp, Inc. Reports 2025 Financial Results

Written by Customer Service on January 28, 2026. Posted in Earnings Releases And Operating Results.

DUNMORE, Pa., Jan. 28, 2026 (GLOBE NEWSWIRE) — Fidelity D & D Bancorp, Inc. (NASDAQ: FDBC) and its banking subsidiary, The Fidelity Deposit and Discount Bank (“the Company”), announced its unaudited, consolidated financial results for the three and twelve month periods ended December 31, 2025. Unaudited Financial Information Net income recorded for the year ended December 31, 2025 was $28.2 million, or $4.86 diluted earnings per share, compared to $20.8 million, or $3.60 diluted earnings per share, for the year ended December 31, 2024. The $7.4 million, or 36% increase in net income resulted primarily from the $10.8 million increase in net interest income and $1.6 million increase in non-interest income partially offset by a $3.3 million increase in non-interest expenses for 2025 compared to 2024. Net income for...

Day: January 28, 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals